Key Points:Transaction to result in NASDAQ-listed company focused in orphan pediatric liver diseasesAlbireo brings wholly owned, Phase 2 lead asset ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE